L. Garcia-Rodriguez

First name
L.
Middle name
A.
Last name
Garcia-Rodriguez
Mannino, S., Garcia-Rodriguez, L. A., & Jick, S. S. (1992). NSAIDs, quinolones and convulsions: An epidemiologic approach.
Perez-Gutthann, S., Garcia-Rodriguez, L. A., Duque-Oliart, A., & Varas-Lorenzo, C. (1999). Low-dose diclofenac, naproxen, and ibuprofen cohort study. Pharmacotherapy.
Varas-Lorenzo, C., Garcia-Rodriguez, L. A., Perez-Gutthann, S., & Duque-Oliart, A. (2000). Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation.
Hernandez-Diaz, S., & Garcia-Rodriguez, L. A. (2001). Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Am J Med.
Garcia-Rodriguez, L. A., & Huerta-Alvarez, C. (2001). Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology.
Castellsague, J., Garcia-Rodriguez, L. A., Duque, A., & Perez, S. (2002). Risk of serious skin disorders among users of oral antifungals: a population-based study. BMC Dermatol.
Hollowell, J., Ruigomez, A., Johansson, S., Wallander, M. A., & Garcia-Rodriguez, L. A. (2003). The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom. Br J Gen Pract.
de Abajo, F. J., & Garcia-Rodriguez, L. A. (2008). Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry. http://doi.org/10.1001/archpsyc.65.7.795
Garcia-Rodriguez, L. A., Masso-Gonzalez, E. L., Wallander, M. A., & Johansson, S. (2008). The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1603
Ruigomez, A., Masso-Gonzalez, E. L., Johansson, S., Wallander, M. A., & Garcia-Rodriguez, L. A. (2009). Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality. Br J Gen Pract. http://doi.org/10.3399/bjgp09X407054